Could donor immune cells beat COVID-19? new trial begins.

NCT ID NCT04896606

Recruiting now Disease control Sponsor: New York Medical College Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether special immune cells (called T cells) taken from a family member who already recovered from COVID-19 can safely treat mild to moderate COVID-19 in hospitalized adults. The cells are designed to attack the virus. The trial involves 50 participants and aims to see if the treatment is safe and helps control the disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID19 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

COVID-19

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COVID19

Contacts and locations

Locations

Children's Hospital of Pennsylvania
NOT_YET_RECRUITING

Philadelphia, Pennsylvania, 19104, United States
Medical College of Wisconsin/Children's Hospital of Wisconsin
NOT_YET_RECRUITING

Milwaukee, Wisconsin, 53226, United States
Nationwide Children's Hosptial
NOT_YET_RECRUITING

Columbus, Ohio, 43205, United States
New York Medical College
RECRUITING

Valhalla, New York, 10595, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.